Literature DB >> 20040531

Re-classifying myositis.

Shabina M Sultan, David A Isenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20040531     DOI： 10.1093/rheumatology/kep355

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

1.  Painful myositis in the anti-synthetase syndrome with anti-PL12 antibodies.

Authors:  Puja Mehta; Leena Patel; Federico Roncaroli; Matthew C Pickering; Alexander Brand
Journal:  Rheumatol Int       Date:  2011-02-17       Impact factor: 2.631

2.  Comparison of the 2017 EULAR/ACR criteria with Bohan and Peter criteria for the classification of idiopathic inflammatory myopathies.

Authors:  Benzeeta Pinto; Ramya Janardana; Raghunanadan Nadig; Anita Mahadevan; Anusha S Bhatt; John Michael Raj; Vineeta Shobha
Journal:  Clin Rheumatol       Date:  2019-03-22       Impact factor: 2.980

3.  Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.

Authors:  Puja Srivastava; Sanjay Dwivedi; Ramnath Misra
Journal:  Rheumatol Int       Date:  2016-05-14       Impact factor: 2.631

Review 4.  The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum.

Authors:  Elizabeth Ghazi; Richard D Sontheimer; Victoria P Werth
Journal:  Clin Exp Rheumatol       Date:  2012-11-22       Impact factor: 4.473

Review 5.  Dermatomyositis Induced by Hepatitis B Virus-related Hepatocellular Carcinoma: A Case Report and Review of the Literature.

Authors:  Jen-Wei Chou; Yin-Lan Lin; Ken-Sheng Cheng; Po-Yuan Wu; Teressa Reanne Ju
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.